1. Home
  2. CANF vs MWG Comparison

CANF vs MWG Comparison

Compare CANF & MWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CANF
  • MWG
  • Stock Information
  • Founded
  • CANF 1994
  • MWG 1988
  • Country
  • CANF Israel
  • MWG Singapore
  • Employees
  • CANF N/A
  • MWG N/A
  • Industry
  • CANF Biotechnology: Pharmaceutical Preparations
  • MWG Miscellaneous manufacturing industries
  • Sector
  • CANF Health Care
  • MWG Consumer Discretionary
  • Exchange
  • CANF Nasdaq
  • MWG Nasdaq
  • Market Cap
  • CANF 14.4M
  • MWG 15.2M
  • IPO Year
  • CANF N/A
  • MWG 2023
  • Fundamental
  • Price
  • CANF $2.46
  • MWG $0.28
  • Analyst Decision
  • CANF Strong Buy
  • MWG
  • Analyst Count
  • CANF 2
  • MWG 0
  • Target Price
  • CANF $14.00
  • MWG N/A
  • AVG Volume (30 Days)
  • CANF 135.4K
  • MWG 842.2K
  • Earning Date
  • CANF 11-15-2024
  • MWG 01-01-0001
  • Dividend Yield
  • CANF N/A
  • MWG N/A
  • EPS Growth
  • CANF N/A
  • MWG 54.92
  • EPS
  • CANF N/A
  • MWG 0.06
  • Revenue
  • CANF $667,000.00
  • MWG $36,016,000.00
  • Revenue This Year
  • CANF $356.93
  • MWG N/A
  • Revenue Next Year
  • CANF N/A
  • MWG N/A
  • P/E Ratio
  • CANF N/A
  • MWG $4.62
  • Revenue Growth
  • CANF N/A
  • MWG N/A
  • 52 Week Low
  • CANF $1.81
  • MWG $0.19
  • 52 Week High
  • CANF $4.69
  • MWG $0.78
  • Technical
  • Relative Strength Index (RSI)
  • CANF 62.91
  • MWG 33.96
  • Support Level
  • CANF $1.87
  • MWG $0.34
  • Resistance Level
  • CANF $2.55
  • MWG $0.42
  • Average True Range (ATR)
  • CANF 0.17
  • MWG 0.05
  • MACD
  • CANF 0.06
  • MWG -0.02
  • Stochastic Oscillator
  • CANF 85.94
  • MWG 1.80

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

About MWG Multi Ways Holdings Limited

Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.

Share on Social Networks: